|
1
|
Roth GA, Mensah GA, Johnson CO, Addolorato
G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ,
Benziger CP, et al: Global burden of cardiovascular diseases and
risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll
Cardiol. 76:2982–3021. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carreño JE, Apablaza F, Ocaranza MP and
Jalil JE: Cardiac hypertrophy: Molecular and cellular events. Rev
Esp Cardiol. 59:473–486. 2006.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shimizu I and Minamino T: Physiological
and pathological cardiac hypertrophy. J Mol Cell Cardiol.
97:245–262. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ciarambino T, Menna G, Sansone G and
Giordano M: Cardiomyopathies: An Overview. Int J Mol Sci.
22:77222021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gallo S, Vitacolonna A, Bonzano A,
Comoglio P and Crepaldi T: ERK: A key player in the pathophysiology
of cardiac hypertrophy. Int J Mol Sci. 20:21642019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kawel-Boehm N, Kronmal R, Eng J, Folsom A,
Burke G, Carr JJ, Shea S, Lima JAC and Bluemke DA: Left ventricular
mass at MRI and long-term risk of cardiovascular events: The
multi-ethnic study of atherosclerosis (MESA). Radiology.
293:107–114. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barbieri A, Bartolacelli Y, Bursi F,
Manicardi M and Boriani G: Remodeling classification system
considering left ventricular volume in patients with aortic valve
stenosis: Association with adverse cardiovascular outcomes.
Echocardiography. 36:639–650. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schirone L, Forte M, Palmerio S, Yee D,
Nocella C, Angelini F, Pagano F, Schiavon S, Bordin A, Carrizzo A,
et al: A review of the molecular mechanisms underlying the
development and progression of cardiac remodeling. Oxid Med Cell
Longev. 2017:39201952017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Haque ZK and Wang DZ: How cardiomyocytes
sense pathophysiological stresses for cardiac remodeling. Cell Mol
Life Sci. 74:983–1000. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakamura M and Sadoshima J: Mechanisms of
physiological and pathological cardiac hypertrophy. Nat Rev
Cardiol. 15:387–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang H, Wang XX, Zhou CY, Xiao X, Tian C,
Li HH, Yin CL and Wang HX: Tripartite motif 10 regulates cardiac
hypertrophy by targeting the PTEN/AKT pathway. J Cell Mol Med.
24:6233–6241. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu S, Chen J, Cai X, Wu J, Chen X, Wu YT,
Sun L and Chen ZJ: MAVS recruits multiple ubiquitin E3 ligases to
activate antiviral signaling cascades. Elife. 2:e007852013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen M, Meng Q, Qin Y, Liang P, Tan P, He
L, Zhou Y, Chen Y, Huang J, Wang RF and Cui J: TRIM14 inhibits cGAS
degradation mediated by selective autophagy receptor p62 to promote
innate immune responses. Mol Cell. 64:105–119. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang F, Ruan L, Yang J, Zhao Q and Wei W:
TRIM14 promotes the migration and invasion of gastric cancer by
regulating epithelialtomesenchymal transition via activation of AKT
signaling regulated by miR1955p. Oncol Rep. 40:3273–3284.
2018.PubMed/NCBI
|
|
15
|
Xu G, Guo Y, Xu D, Wang Y, Shen Y, Wang F,
Lv Y, Song F, Jiang D, Zhang Y, et al: TRIM14 regulates cell
proliferation and invasion in osteosarcoma via promotion of the AKT
signaling pathway. Sci Rep. 7:424112017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hai J, Zhu CQ, Wang T, Organ SL, Shepherd
FA and Tsao MS: TRIM14 is a putative tumor suppressor and regulator
of innate immune response in non-small cell lung cancer. Sci Rep.
7:396922017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang S, Chen Y, Li C, Wu Y, Guo L, Peng C,
Huang Y, Cheng G and Qin FX: TRIM14 inhibits hepatitis C virus
infection by SPRY domain-dependent targeted degradation of the
viral NS5A protein. Sci Rep. 6:323362016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu X, Wang J, Wang S, Wu F, Chen Z, Li C,
Cheng G and Qin FX: Inhibition of influenza A virus replication by
TRIM14 via its multifaceted protein-protein interaction with NP.
Front Microbiol. 10:3442019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu G, Liu Y, Huang H, Tang Y, Liu W, Mei
Y, Wan N, Liu X and Huang C: SH2B1 is critical for the regulation
of cardiac remodelling in response to pressure overload. Cardiovasc
Res. 107:203–215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Z, Zhang XJ, Ji YX, Zhang P, Deng KQ,
Gong J, Ren S, Wang X, Chen I, Wang H, et al: The long noncoding
RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy.
Nat Med. 22:1131–1139. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakamura Y, Kita S, Tanaka Y, Fukuda S,
Obata Y, Okita T, Kawachi Y, Tsugawa-Shimizu Y, Fujishima Y,
Nishizawa H, et al: A disintegrin and metalloproteinase 12 prevents
heart failure by regulating cardiac hypertrophy and fibrosis. Am J
Physiol Heart Circ Physiol. 318:H238–H251. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen W, Jin Z, Tong X, Wang H, Zhuang L,
Lu X and Wu S: TRIM14 promotes cell proliferation and inhibits
apoptosis by suppressing PTEN in colorectal cancer. Cancer Manag
Res. 11:5725–5735. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng S, Cai X, Li Y, Jian X, Zhang L and
Li B: Tripartite motif-containing 14 (TRIM14) promotes
epithelial-mesenchymal transition via ZEB2 in glioblastoma cells. J
Exp Clin Cancer Res. 38:572019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu H, Sun B and Shen Q: TNF-α induces
apoptosis of human nucleus pulposus cells via activating the
TRIM14/NF-κB signalling pathway. Artif Cells Nanomed
Biotechnol. 47:3004–3012. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou Z, Jia X, Xue Q, Dou Z, Ma Y, Zhao Z,
Jiang Z, He B, Jin Q and Wang J: TRIM14 is a mitochondrial adaptor
that facilitates retinoic acid-inducible gene-I-like
receptor-mediated innate immune response. Proc Natl Acad Sci USA.
111:E245–E254. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nenasheva VV, Nikolaev AI, Martynenko AV,
Kaplanskaya IB, Bodemer W, Hunsmann G and Tarantul VZ: Differential
gene expression in HIV/SIV-associated and spontaneous lymphomas.
Int J Med Sci. 2:122–128. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tan G, Xu F, Song H, Yuan Y, Xiao Q, Ma F,
Qin FX and Cheng G: Identification of TRIM14 as a type I
IFN-stimulated gene controlling hepatitis B virus replication by
targeting HBx. Front Immunol. 9:18722018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qiao CY, Qiao TY, Jin H, Liu LL, Zheng MD
and Wang ZL: LncRNA KCNQ1OT1 contributes to the cisplatin
resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14
axis. Eur Rev Med Pharmacol Sci. 24:200–212. 2020.PubMed/NCBI
|
|
29
|
Huang CY, Pai PY, Kuo CH, Ho TJ, Lin JY,
Lin DY, Tsai FJ, Padma VV, Kuo WW and Huang CY: p53-mediated miR-18
repression activates HSF2 for IGF-IIR-dependent myocyte hypertrophy
in hypertension-induced heart failure. Cell Death Dis. 8:e29902017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kumar S, Wang G, Zheng N, Cheng W, Ouyang
K, Lin H, Liao Y and Liu J: HIMF (hypoxia-induced mitogenic
factor)-IL (interleukin)-6 signaling mediates
cardiomyocyte-fibroblast crosstalk to promote cardiac hypertrophy
and fibrosis. Hypertension. 73:1058–1070. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen L, Huang J, Ji YX, Mei F, Wang PX,
Deng KQ, Jiang X, Ma G and Li H: Tripartite motif 8 contributes to
pathological cardiac hypertrophy through enhancing transforming
growth factor β-activated kinase 1-dependent signaling pathways.
Hypertension. 69:249–258. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen L, Huang J, Ji Y, Zhang X, Wang P,
Deng K, Jiang X, Ma G and Li H: Tripartite motif 32 prevents
pathological cardiac hypertrophy. Clin Sci (Lond). 130:813–828.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Al Asoom LI: Molecular mechanisms of
Nigella sativa- and Nigella sativa exercise-induced cardiac
hypertrophy in rats. Evid Based Complement Alternat Med.
2021:55530222021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen Y, Liu Z, Hu Z, Feng X and Zuo L:
Tripartite motif 27 promotes cardiac hypertrophy via PTEN/Akt/mTOR
signal pathways. Bioengineered. 13:8323–8333. 2022.PubMed/NCBI
|
|
35
|
Kumar S, Wang G, Liu W, Ding W, Dong M,
Zheng N, Ye H and Liu J: Hypoxia-induced mitogenic factor promotes
cardiac hypertrophy via calcium-dependent and hypoxia-inducible
factor-1α mechanisms. Hypertension. 72:331–342. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yan K, Ponnusamy M, Xin Y, Wang Q, Li P
and Wang K: The role of K63-linked polyubiquitination in cardiac
hypertrophy. J Cell Mol Med. 22:4558–4567. 2018. View Article : Google Scholar : PubMed/NCBI
|
